FDA expands organ-on-a-chip research collaboration
Drug Discovery World
JANUARY 18, 2023
The system will initially be investigated for improving the preclinical estimation of human drug bioavailability compared to standard animal models. . Dr Emily Richardson, Lead Scientist at CN Bio, said: “We are extremely pleased with the FDA’s decision to deepen our research collaboration into the multi-organ space.
Let's personalize your content